NexturnBioscience (Korea) Buy Hold or Sell Recommendation
| 089140 Stock | KRW 3,395 100.00 3.03% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding NexturnBioscience Co is 'Cautious Hold'. Macroaxis provides NexturnBioscience buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 089140 positions.
Check out NexturnBioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as NexturnBioscience and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards NexturnBioscience Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
NexturnBioscience |
Execute NexturnBioscience Buy or Sell Advice
The NexturnBioscience recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NexturnBioscience Co. Macroaxis does not own or have any residual interests in NexturnBioscience Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NexturnBioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
NexturnBioscience Trading Alerts and Improvement Suggestions
| NexturnBioscience had very high historical volatility over the last 90 days | |
| The company reported the revenue of 16.97 B. Net Loss for the year was (4 B) with profit before overhead, payroll, taxes, and interest of 3 B. | |
| About 24.0% of the company shares are owned by insiders or employees |
NexturnBioscience Returns Distribution Density
The distribution of NexturnBioscience's historical returns is an attempt to chart the uncertainty of NexturnBioscience's future price movements. The chart of the probability distribution of NexturnBioscience daily returns describes the distribution of returns around its average expected value. We use NexturnBioscience Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NexturnBioscience returns is essential to provide solid investment advice for NexturnBioscience.
| Mean Return | 0.36 | Value At Risk | -9.37 | Potential Upside | 8.97 | Standard Deviation | 7.80 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NexturnBioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NexturnBioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NexturnBioscience or Industrials sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NexturnBioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NexturnBioscience stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.48 | |
β | Beta against Dow Jones | -1.06 | |
σ | Overall volatility | 8.26 | |
Ir | Information ratio | 0.03 |
NexturnBioscience Volatility Alert
NexturnBioscience Co is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NexturnBioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NexturnBioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NexturnBioscience Fundamentals Vs Peers
Comparing NexturnBioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NexturnBioscience's direct or indirect competition across all of the common fundamentals between NexturnBioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as NexturnBioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of NexturnBioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing NexturnBioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare NexturnBioscience to competition |
| Fundamentals | NexturnBioscience | Peer Average |
| Return On Equity | 2.07 | -0.31 |
| Return On Asset | 0.0793 | -0.14 |
| Profit Margin | 0.10 % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 170.8 B | 16.62 B |
| Shares Outstanding | 10.43 M | 571.82 M |
| Shares Owned By Insiders | 24.07 % | 10.09 % |
| Shares Owned By Institutions | 0.27 % | 39.21 % |
| Price To Earning | 78.14 X | 28.72 X |
| Price To Sales | 0.68 X | 11.42 X |
| Revenue | 16.97 B | 9.43 B |
| Gross Profit | 3 B | 27.38 B |
| EBITDA | (1.61 B) | 3.9 B |
| Net Income | (4 B) | 570.98 M |
| Cash And Equivalents | 20.63 B | 2.7 B |
| Total Debt | 2.19 B | 5.32 B |
| Current Ratio | 26.50 X | 2.16 X |
| Book Value Per Share | 6,540 X | 1.93 K |
| Cash Flow From Operations | 3.66 B | 971.22 M |
| Target Price | 7500.0 | |
| Number Of Employees | 56 | 18.84 K |
| Beta | 1.05 | -0.15 |
| Market Capitalization | 18.28 B | 19.03 B |
| Total Asset | 138.95 B | 29.47 B |
| Retained Earnings | 24.52 B | 9.33 B |
| Working Capital | 30.56 B | 1.48 B |
| Current Asset | 32.78 B | 9.34 B |
| Current Liabilities | 2.22 B | 7.9 B |
| Z Score | 4.8 | 8.72 |
| Annual Yield | 0.01 % | |
| Net Asset | 138.95 B |
NexturnBioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NexturnBioscience . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 188014.0 | |||
| Daily Balance Of Power | 0.2198 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 3512.5 | |||
| Day Typical Price | 3473.33 | |||
| Market Facilitation Index | 3.0E-4 | |||
| Price Action Indicator | (67.50) | |||
| Period Momentum Indicator | 100.0 |
About NexturnBioscience Buy or Sell Advice
When is the right time to buy or sell NexturnBioscience Co? Buying financial instruments such as NexturnBioscience Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NexturnBioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in NexturnBioscience Stock
NexturnBioscience financial ratios help investors to determine whether NexturnBioscience Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NexturnBioscience with respect to the benefits of owning NexturnBioscience security.